Identifying Patients at Risk of Multiple Myeloma Relapse Can Improve Treatment Plans

Moffitt researchers lead national effort to refine risk-stratification tools to improve patient outcomes

Accelerating Impact Through Global Partnership

Moffitt is redefining the cancer treatment landscape through a series of groundbreaking international partnerships

Teacher Spreads Awareness as Colorectal Cancer Cases Rise in Young Adults

Moffitt experts say about 15% of colorectal patients are under 50 years old

Moffitt Cancer Center Leaders Highlight Importance of Cancer Research in D.C.

Ongoing cancer research funding is essential to Moffitt’s mission

Single-Drug Immunotherapy Shows Success in Rare Skin Cancer

Pembrolizumab delivers 89% response rate in desmoplastic melanoma, sparing patients from harsher combination treatments

Moffitt Study Uncovers New Mechanism of Immunotherapy Resistance

Cancer-induced nerve injury weakens anti-PD-1 treatment, but novel approaches may overcome it

Powered by Positivity in the Fight Against Kidney Cancer

Moffitt patient’s outlook combines determination, faith and support

Dendritic Cell Vaccines Changing Landscape for Breast Cancer Treatment

Moffitt research shows promise in breakthrough immunotherapy treatment

Improving Outcomes for Patients With Synovial Sarcoma

Moffitt treats first patient in the world with FDA-approved Tecelra

Endeavor